Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes
The genetics of keratoconus
It is not a lifestyle choice. Finding a clinician without anti-fat bias [archived link] who is concerned about your overall health and addresses underlying causes is important regardless of whether you take a GLP-1 RA medication
Recent FDA Approvals and the Future of GLP-1 Agonists The pronounced success of GLP-1-based therapies has led to numerous FDA approvals for managing type 2 diabetes and obesity (Kommu S et al., 2025
In vitro stability assay with high glutathione concentration GLP-1MK-801 was dissolved in dimethyl sulfoxide at a concentration of 0.25 mM and diluted with a solution of 200 mM glutathione in PBS, pH 7, such that the final concentration of GLP-1MK-801 in the assay was 100 M
Continuous glucose monitoring and insulin informed advisory system with automated titration and dosing of insulin reduces glucose variability in type 1 diabetes mellitus